§NASH affects 12 million people in the US today
§ Patients with severe NASH fibrosis have a median overall  survival of 5 years
§ Direct costs of care for NASH in US market are currently $103 billion annually
§ Direct costs of care expected to grow to $1 trillion annually by 2027


Print Print | Sitemap
© Bast Biotechnology - Powered by IONOS